CPMD Stock Overview
CannaPharmaRX, Inc. operates in the cannabis industry in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CannaPharmaRX, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.01 |
| 52 Week High | US$0.028 |
| 52 Week Low | US$0.000001 |
| Beta | -1190.54 |
| 1 Month Change | -39.39% |
| 3 Month Change | 614.29% |
| 1 Year Change | -1.96% |
| 3 Year Change | -95.00% |
| 5 Year Change | -99.42% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CPMD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | -2.0% | 10.6% | 21.9% |
Price Volatility
| CPMD volatility | |
|---|---|
| CPMD Average Weekly Movement | 60.4% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CPMD's share price has been volatile over the past 3 months.
Volatility Over Time: CPMD's weekly volatility has decreased from 129083% to 60% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 6 | Dean Medwid | www.cannapharmarx.com |
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.
CannaPharmaRX, Inc. Fundamentals Summary
| CPMD fundamental statistics | |
|---|---|
| Market cap | US$6.54m |
| Earnings (TTM) | -US$7.50m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.9x
P/E RatioIs CPMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPMD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$7.50m |
| Earnings | -US$7.50m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -53.1% |
How did CPMD perform over the long term?
See historical performance and comparison